CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 160 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $53,416 | +38.6% | 1,941 | +70.9% | 0.00% | – |
Q2 2023 | $38,544 | +67.4% | 1,136 | +77.5% | 0.00% | – |
Q1 2023 | $23,027 | -12.6% | 640 | +8.3% | 0.00% | – |
Q4 2022 | $26,340 | +64.6% | 591 | -2.2% | 0.00% | – |
Q3 2022 | $16,000 | -75.0% | 604 | -74.9% | 0.00% | – |
Q2 2022 | $64,000 | -92.0% | 2,403 | -89.8% | 0.00% | -100.0% |
Q1 2022 | $804,000 | -10.7% | 23,633 | +1.4% | 0.00% | 0.0% |
Q4 2021 | $900,000 | – | 23,299 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |